Table 3 Clinical characteristics of 25 patents with confirmed A (H7N9) virus infection in Guangzhou and 16 healthy controls
Clinical characteristic | Health controls n = 16 | Percent (%) | Case n = 25 | Percent (%) | P * | Death (%) | ARDS (%) | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Fatal (n = 14) | Nonfatal (n = 11) | P | No (n = 10) | Yes (n = 15) | P | ||||||
Elevated CRP | 21 | 84 | 14 (100.0) | 7 (63.6) | 0.026 | 6 (60) | 15 (100) | 0.017 | |||
Leukopenia | 0 | 0.0 | 9 | 36 | 0.024 | 6 (42.9) | 3 (27.3) | 0.667 | 3 (30.0) | 6 (40.0) | 0.691 |
Lymphocytopenia | 11 | 68.8 | 20 | 80 | 0.472 | 13 (92.9) | 7 (63.6) | 0.096 | 5 (50) | 15 (100) | 0.005 |
Thrombocytopenia | 0 | 0.0 | 5 | 20 | 0.374 | 3 (21.4) | 2 (18.2) | 1.000 | 1 (10.0) | 4 (26.7) | 0.615 |
Neutropenia | 1 | 6.3 | 6 | 24 | 0.215 | 4 (28.6) | 2 (18.2) | 0.664 | 3 (30.0) | 3 (20.0) | 0.653 |
Neutrophilia | 10 | 62.5 | 7 | 28 | 0.029 | 6 (42.9) | 1 (9.1) | 0.090 | 1 (10.0) | 6 (40.0 %) | 0.179 |
Elevated TT | 0 | 0.0 | 7 | 28 | 0.114 | 5 (35.7) | 2 (18.2) | 0.407 | 1 (10.0) | 6 (40.0) | 0.179 |
Elevated APTT | 1 | 6.3 | 13 | 52 | 0.002 | 9 (64.3) | 4 (36.4) | 0.238 | 4 (40.0) | 9 (60.0) | 0.428 |
Elevated ALT | 2 | 12.5 | 10 | 40 | 0.084 | 6 (42.9) | 4 (36.4) | 1.000 | 2 (28.6) | 8 (53.3) | 0.211 |
Elevated AST | 3 | 18.8 | 18 | 72 | 0.001 | 11 (78.6) | 7 (63.6) | 0.656 | 4 (40.0) | 14 (93.3) | 0.007 |
Elevated LDH | 5 | 31.3 | 20 | 80 | 0.002 | 12 (85.7) | 8 (72.7) | 0.623 | 6 (60.0) | 14 (93.3) | 0.121 |
Elevated CK | 3 | 18.8 | 15 | 60 | 0.009 | 10 (71.4) | 5 (45.5) | 0.241 | 2 (20.0) | 13 (86.7) | 0.002 |
Elevated CRE | 0 | 0.0 | 8 | 32 | 0.060 | 6 (42.9) | 2 (18.2) | 0.234 | 2 (20.0) | 6 (40.0) | 0.402 |